Vitamin C Status Is Related to Proinflammatory Responses and Impaired Vascular Endothelial Function in Healthy, College-Aged Lean and Obese Men

Journal of the American Dietetic Association

Volumn 111, Issue 5, 2011, Pages 737-743

  Mah, Eunice ^a   Matos, Manuel D ^a   Kawiecki, Diana ^a   Ballard, Kevin ^a   Guo, Yi ^a   Volek, Jeff S ^a   Bruno, Richard S ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CYTOKINE; PEROXIDASE;

ADULT; ARTICLE; BLOOD; BLOOD FLOW VELOCITY; BODY WEIGHT; BRACHIAL ARTERY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; ECHOGRAPHY; HUMAN; INFLAMMATION; MALE; METABOLISM; NUTRITIONAL STATUS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; ASCORBIC ACID; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; CROSS-SECTIONAL STUDIES; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MALE; NUTRITIONAL STATUS; OBESITY; PEROXIDASE; THINNESS; VITAMIN E; YOUNG ADULT;

EID: 79955084922     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2011.02.003     Document Type: Article

References (53)

1. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., Ford E., Furie K., Go A., Greenlund K., Haase N., Hailpern S., Ho M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M., Meigs J., Mozaffarian D., Nichol G., O'Donnell C., Roger V., Rosamond W., Sacco R., Sorlie P., Stafford R., Steinberger J., Thom T., Wasserthiel-Smoller S., Wong N., Wylie-Rosett J., Hong Y. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
2. Kannel W.B., Wilson P.W., Nam B.H., D'Agostino R.B. Risk stratification of obesity as a coronary risk factor. Am J Cardiol 2002, 90:697-701.
3. Rueda-Clausen C.F., Lahera V., Calderon J., Bolivar I.C., Castillo V.R., Gutierrez M., Carreno M., Oubina Mdel P., Cachofeiro V., Lopez-Jaramillo P. The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors. Int J Cardiol 2010, 139:32-41.
4. Engstrom G., Hedblad B., Stavenow L., Jonsson S., Lind P., Janzon L., Lindgarde F. Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: A population-based cohort study. Arterioscler Thromb Vasc Biol 2004, 24:1498-1502.
5. Keaney J.F., Larson M.G., Vasan R.S., Wilson P.W., Lipinska I., Corey D., Massaro J.M., Sutherland P., Vita J.A., Benjamin E.J. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003, 23:434-439.
6. Behrendt D., Ganz P. Endothelial function. From vascular biology to clinical applications. Am J Cardiol 2002, 90:40L-48L.
7. Harris R.A., Nishiyama S.K., Wray D.W., Richardson R.S. Ultrasound assessment of flow-mediated dilation. Hypertension 2010, 55:1075-1085.
8. Arkin J.M., Alsdorf R., Bigornia S., Palmisano J., Beal R., Istfan N., Hess D., Apovian C.M., Gokce N. Relation of cumulative weight burden to vascular endothelial dysfunction in obesity. Am J Cardiol 2008, 101:98-101.
9. Yeboah J., Folsom A.R., Burke G.L., Johnson C., Polak J.F., Post W., Lima J.A., Crouse J.R., Herrington D.M. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation 2009, 120:502-509.
10. Chrysohoou C., Panagiotakos D.B., Pitsavos C., Skoumas I., Papademetriou L., Economou M., Stefanadis C. The implication of obesity on total antioxidant capacity in apparently healthy men and women: The ATTICA study. Nutr Metab Cardiovasc Dis 2007, 17:590-597.
11. Silver A.E., Beske S.D., Christou D.D., Donato A.J., Moreau K.L., Eskurza I., Gates P.E., Seals D.R. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 2007, 115:627-637.
12. Nicholls S.J., Hazen S.L. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 2005, 25:1102-1111.
13. Meuwese M.C., Stroes E.S., Hazen S.L., van Miert J.N., Kuivenhoven J.A., Schaub R.G., Wareham N.J., Luben R., Kastelein J.J., Khaw K.T., Boekholdt S.M. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: The EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007, 50:159-165.
14. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith S.C., Taubert K., Tracy R.P., Vinicor F. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
15. Nijhuis J., Rensen S.S., Slaats Y., van Dielen F.M., Buurman W.A., Greve J.W. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring) 2009, 17:2014-2018.
16. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?. Atherosclerosis 2000, 148:209-214.
17. Carr A.C., Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999, 69:1086-1107.
18. Antoniades C., Tousoulis D., Tountas C., Tentolouris C., Toutouza M., Vasiliadou C., Tsioufis C., Toutouzas P., Stefanadis C. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: The effects of vitamin C. Diabet Med 2004, 21:552-558.
19. Raitakari O.T., Adams M.R., McCredie R.J., Griffiths K.A., Stocker R., Celermajer D.S. Oral vitamin C and endothelial function in smokers: Short-term improvement, but no sustained beneficial effect. J Am Coll Cardiol 2000, 35:1616-1621.
20. Solzbach U., Hornig B., Jeserich M., Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997, 96:1513-1519.
21. Gokce N., Keaney J.F., Frei B., Holbrook M., Olesiak M., Zachariah B.J., Leeuwenburgh C., Heinecke J.W., Vita J.A. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999, 99:3234-3240.
22. Cook N.R., Albert C.M., Gaziano J.M., Zaharris E., MacFadyen J., Danielson E., Buring J.E., Manson J.E. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007, 167:1610-1618.
23. Sesso H.D., Buring J.E., Christen W.G., Kurth T., Belanger C., MacFadyen J., Bubes V., Manson J.E., Glynn R.J., Gaziano J.M. Vitamins E and C in the prevention of cardiovascular disease in men: The Physicians' Health Study II randomized controlled trial. JAMA 2008, 300:2123-2133.
24. Lieb W., Safa R., Benjamin E.J., Xanthakis V., Yin X., Sullivan L.M., Larson M.G., Smith H.M., Vita J.A., Mitchell G.F., Sawyer D.B., Vasan R.S. Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: Clinical and genetic correlates and association with vascular function. Eur Heart J 2009, 30:1121-1127.
25. Mercuro G., Deidda M., Piras A., Dessalvi C.C., Maffei S., Rosano G.M. Gender determinants of cardiovascular risk factors and diseases. J Cardiovasc Med (Hagerstown) 2010, 11:207-220.
26. Jackson A.S., Pollock M.L. Generalized equations for predicting body density of men. Br J Nutr 1978, 40:497-504.
27. Schutte J.E., Townsend E.J., Hugg J., Shoup R.F., Malina R.M., Blomqvist C.G. Density of lean body mass is greater in blacks than in whites. J Appl Physiol 1984, 56:1647-1649.
28. Siri W.E. Body composition from fluid spaces and density: Analysis of methods. Techniques for Measuring Body Composition 1961, 223-245. National Academy of Sciences, Washington, DC. J. Brozek, A. Henschel (Eds.).
29. Ballard K.D., Bruno R.S., Seip R.L., Quann E.E., Volk B.M., Freidenreich D.J., Kawiecki D.M., Kupchak B.R., Chung M.Y., Kraemer W.J., Volek J.S. Acute ingestion of a novel whey-derived peptide improves vascular endothelial responses in healthy individuals: A randomized, placebo controlled trial. Nutr J 2009, 8:34-44.
30. Doshi S.N., Naka K.K., Payne N., Jones C.J., Ashton M., Lewis M.J., Goodfellow J. Flow-mediated dilatation following wrist and upper arm occlusion in humans: The contribution of nitric oxide. Clin Sci (Lond) 2001, 101:629-635.
31. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
32. Huang D., Ou B., Hampsch-Woodill M., Flanagan J.A., Prior R.L. High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format. J Agric Food Chem 2002, 50:4437-4444.
33. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem 1996, 239:70-76.
34. Bruno R.S., Dugan C.E., Smyth J.A., DiNatale D.A., Koo S.I. Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J Nutr 2008, 138:323-331.
35. Freiser H., Jiang Q. Optimization of the enzymatic hydrolysis and analysis of plasma conjugated gamma-CEHC and sulfated long-chain carboxychromanols, metabolites of vitamin E. Anal Biochem 2009, 388:260-265.
36. Jones D.P., Carlson J.L., Samiec P.S., Sternberg P., Mody V.C., Reed R.L., Brown L.A. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta 1998, 275:175-184.
37. Hashimoto M., Akishita M., Eto M., Kozaki K., Ako J., Sugimoto N., Yoshizumi M., Toba K., Ouchi Y. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord 1998, 22:477-484.
38. Weinhold B., Ruther U. Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J 1997, 327(Pt 2):425-429.
39. Schleicher R.L., Carroll M.D., Ford E.S., Lacher D.A. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES). Am J Clin Nutr 2009, 90:1252-1263.
40. Strazzullo P., Puig J.G. Uric acid and oxidative stress: Relative impact on cardiovascular risk. Nutr Metab Cardiovasc Dis 2007, 17:409-414.
41. Nyyssonen K., Parviainen M.T., Salonen R., Tuomilehto J., Salonen J.T. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997, 314:634-638.
42. Ardigo D., Franzini L., Valtuena S., Monti L.D., Reaven G.M., Zavaroni I. Relation of plasma insulin levels to forearm flow-mediated dilatation in healthy volunteers. Am J Cardiol 2006, 97:1250-1254.
43. Fung T.T., McCullough M.L., Newby P.K., Manson J.E., Meigs J.B., Rifai N., Willett W.C., Hu F.B. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2005, 82:163-173.
44. Dickinson K.M., Keogh J.B., Clifton P.M. Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr 2009, 89:485-490.
45. Keogh J.B., Grieger J.A., Noakes M., Clifton P.M. Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol 2005, 25:1274-1279.
46. Block G., Norkus E., Hudes M., Mandel S., Helzlsouer K. Which plasma antioxidants are most related to fruit and vegetable consumption?. Am J Epidemiol 2001, 154:1113-1118.
47. Joshipura K.J., Hu F.B., Manson J.E., Stampfer M.J., Rimm E.B., Speizer F.E., Colditz G., Ascherio A., Rosner B., Spiegelman D., Willett W.C. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001, 134:1106-1114.
48. d'Uscio L.V., Milstien S., Richardson D., Smith L., Katusic Z.S. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 2003, 92:88-95.
49. Rayment S.J., Shaw J., Woollard K.J., Lunec J., Griffiths H.R. Vitamin C supplementation in normal subjects reduces constitutive ICAM-1 expression. Biochem Biophys Res Commun 2003, 308:339-345.
50. Vissers M.C., Wilkie R.P. Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1alpha. J Leukoc Biol 2007, 81:1236-1244.
51. Zhang C., Yang J., Jacobs J.D., Jennings L.K. Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: Implications for vascular diseases. Am J Physiol Heart Circ Physiol 2003, 285:H2563-H2572.
52. Bigornia S.J., Mott M.M., Hess D.T., Apovian C.M., McDonnell M.E., Duess M.A., Kluge M.A., Fiscale A.J., Vita J.A., Gokce N. Long-term successful weight loss improves vascular endothelial function in severely obese individuals. Obesity (Silver Spring) 2010, 18:754-759.
53. Ayyad C., Andersen T. Long-term efficacy of dietary treatment of obesity: A systematic review of studies published between 1931 and 1999. Obes Rev 2000, 1:113-119.